...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: AGM - High Level Summary

It could be that my RVX shares were purchased as RVXCF on the US OTC. The shares may have a marketable value on the Canadien Toronto exchange. I'm not quite sure and am waiting this out - certainly there will be some direction forthcoming from the AGM - I am hoping for a pleasant surprise

Share
New Message
Please login to post a reply